Crossmark

Targeting the Hippo pathway in cancer

Crossref DOI link: https://doi.org/10.1038/s41573-025-01234-0

Published Online: 2025-06-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Harvey, Kieran F. https://orcid.org/0000-0001-7845-369X
Tang, Tracy T.
License Information

Text and Data Mining valid from 2025-06-30

Version of Record valid from 2025-06-30
More Information

Article History

Accepted: 29 May 2025

First Online: 30 June 2025

Competing interests

: T.T.T. reports employment with Vivace Therapeutics and has equity interest in Vivace Therapeutics. K.F.H. declares no competing interests.